CTLA4 and posterior cortical atrophy: CP-506 is being tested in combination with carboplatin or a selection of ICB agents (NCT04954599) and Evofosfamide is being tested with ICB (Ipilimumab/anti-CTLA4) (NCT03098160) in a variety of solid tumors, including PCa.